Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 30, 2021 - Issue 11
Submit an article Journal homepage
493
Views
6
CrossRef citations to date
0
Altmetric
Drug Evaluation

Derazantinib: an investigational drug for the treatment of cholangiocarcinoma

Stephan BraunDevelopment, Basilea Pharmaceutica International Ltd, Basel, SwitzerlandCorrespondence[email protected]
,
Paul McSheehyDevelopment, Basilea Pharmaceutica International Ltd, Basel, Switzerland
,
Karine LitherlandDevelopment, Basilea Pharmaceutica International Ltd, Basel, Switzerland
,
Phil McKernanDevelopment, Basilea Pharmaceutica International Ltd, Basel, Switzerland
,
Nicole Forster-GrossDevelopment, Basilea Pharmaceutica International Ltd, Basel, Switzerland
,
Felix BachmannDevelopment, Basilea Pharmaceutica International Ltd, Basel, Switzerland
,
Mahmoud El-ShemerlyDevelopment, Basilea Pharmaceutica International Ltd, Basel, Switzerland
,
Miryana Dimova-DobrevaDevelopment, Basilea Pharmaceutica International Ltd, Basel, Switzerland
,
Inessa PolyakovaDevelopment, Basilea Pharmaceutica International Ltd, Basel, Switzerland
,
Manuel HäcklDevelopment, Basilea Pharmaceutica International Ltd, Basel, Switzerland
,
Ping ZhouDevelopment, Basilea Pharmaceutica International Ltd, Basel, Switzerland
,
Heidi LaneDevelopment, Basilea Pharmaceutica International Ltd, Basel, Switzerland
,
Laurenz KellenbergerDevelopment, Basilea Pharmaceutica International Ltd, Basel, Switzerland
&
Marc EngelhardtDevelopment, Basilea Pharmaceutica International Ltd, Basel, Switzerland
 show all
Pages 1071-1080 | Received 26 Aug 2021, Accepted 15 Oct 2021, Published online: 09 Nov 2021

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ya-nan Liu, Jie Chen, Xinhao Xu, Yingying Hu, Jin-yu Hu, Ren-ai Xu & Guanyang Lin. (2023) Lack of pharmacokinetic interaction between derazantinib and naringin in rats. Pharmaceutical Biology 61:1, pages 514-519.
Read now

Articles from other publishers (5)

Jiachen Wen, Siyuan Wang, Rongxian Guo & Dan Liu. (2023) CSF1R inhibitors are emerging immunotherapeutic drugs for cancer treatment. European Journal of Medicinal Chemistry 245, pages 114884.
Crossref
Kun Pang, Wei Wang, Jia‐Xin Qin, Zhen‐Duo Shi, Lin Hao, Yu‐Yang Ma, Hao Xu, Zhuo‐Xun Wu, Deng Pan, Zhe‐Sheng Chen & Cong‐Hui Han. (2022) Role of protein phosphorylation in cell signaling, disease, and the intervention therapy. MedComm 3:4.
Crossref
Chenyu Sun, Shaodi Ma, Yue Chen, Na Hyun Kim, Sujatha Kailas, Yichen Wang, Wenchao Gu, Yisheng Chen, John Pocholo W. Tuason, Chandur Bhan, Nikitha Manem, Yuting Huang, Ce Cheng, Zhen Zhou, Qin Zhou & Yanzhe Zhu. (2022) Diagnostic Value, Prognostic Value, and Immune Infiltration of LOX Family Members in Liver Cancer: Bioinformatic Analysis. Frontiers in Oncology 12.
Crossref
Alessandro Rizzo, Angela Dalia Ricci, Antonio Cusmai, Silvana Acquafredda, Giuseppe De Palma, Giovanni Brandi & Gennaro Palmiotti. (2022) Systemic Treatment for Metastatic Biliary Tract Cancer: State of the Art and a Glimpse to the Future. Current Oncology 29:2, pages 551-564.
Crossref
Louisa Hempel, Constantin Lapa, Alexander Dierks, Andreas Gaumann, Josef Scheiber, Julia Veloso de Oliveira, Patrick Philipp, Cristina Oyarzun Laura, Stefan Wesarg, Sebastian Robert & Dirk Hempel. (2022) A new promising oncogenic target (p.C382R) for treatment with pemigatinib in patients with cholangiocarcinoma. Therapeutic Advances in Medical Oncology 14, pages 175883592211250.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.